Upper limb function · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Live birth rate per woman ‐ short protocol GnRH‐antagonist · women with polycystic ovary syndrome
Metformin may leads to lower live birth rate per woman ‐ short protocol GnRH‐antagonist compared with placebo or no treatment (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women with polycystic ovary syndrome
It is very uncertain whether metformin changes clinical pregnancy rate per woman ‐ short protocol GnRH‐antagonist compared with placebo or no treatment (very low certainty).
Aggression: trait Assessed by: Buss‐Perry Aggression Questionnaire ‐ Short Form (12 items rated on 5‐point Likert scale ranging from extremely uncharacteristic (1) to extremely characteristic (5); range = 12‐60; high score = poor outcome) Timing o... · adults with antisocial personality disorder
1 finding from 1 review
Short‐term impact (< 12 months) child vegetable intake · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) unintended adverse events · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) unintended adverse events · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) unintended adverse events ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Fear of falling scores at 6 months Assessed by Short Falls Efficacy Scale‐International · older adults (aged 60 and over) with irreversible visual impairment
The intervention showed no clear difference in fear of falling scores at 6 months Assessed by Short Falls Efficacy… (low certainty).
1 finding from 1 review
Intervention not reported
Quality of life at 6 months Assessed by 12‐Item Short Form Health Survey · older adults (aged 60 and over) with irreversible visual impairment
The intervention showed no clear difference in quality of life at 6 months Assessed by 12‐Item Short Form Health… (low certainty).
1 finding from 1 review
Intervention not reported
Fear of falling scores at 6 months Assessed by Short Falls Efficacy Scale‐International · older adults (aged 60 and over) with irreversible visual impairment
The intervention showed no clear difference in fear of falling scores at 6 months Assessed by Short Falls Efficacy… (low certainty).
1 finding from 1 review
All‐cause short‐term mortality: range 15 to 31 days · people with cardiogenic shock or low cardiac output syndrome
Levosimendan showed no clear difference in all‐cause short‐term mortality: range 15 to 31 days compared with dobutamine (low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 1 month · adults with low cardiac output syndrome
It is very uncertain whether enoximone changes all‐cause short‐term mortality: 1 month compared with dobutamine (very low certainty).
1 finding from 1 review